Jejunal wall triglyceride concentration of morbidly obese persons is lower in those with type 2 diabetes mellitus

Journal of Lipid Research

Volumn 51, Issue 12, 2010, Pages 3516-3523

  Soriguer, F ^a,b   Garcia Serrano S ^b   Garrido Sanchez L ^c   Gutierrez Repiso, C ^a,d   Rojo Martinez G ^a,b,d   Garcia Escobar, E ^b   Garcia Arnes J ^a   Gallego Perales, J L ^a   Delgado, V ^a   García Fuentes, Eduardo ^a,c,d  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d Hospital University Carlos Haya de Málaga   (Spain)

Author keywords

Angiopoietin like protein 4; Apolipoprotein A IV; Apolipoprotein B48; Chylomicron; Insulin resistance; Intestine; Morbid obesity

Indexed keywords

ANGIOPOIETIN LIKE PROTEIN 4; APOLIPOPROTEIN A4; APOLIPOPROTEIN B48; CHYLOMICRON; GROWTH FACTOR; MESSENGER RNA; METFORMIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; JEJUNUM; LIPID METABOLISM; LOW CALORY DIET; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROUX Y ANASTOMOSIS; STOMACH BYPASS;

APOLIPOPROTEIN B-48; APOLIPOPROTEINS A; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; JEJUNUM; OBESITY, MORBID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRIGLYCERIDES;

EID: 78650061713     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M007815     Document Type: Article

References (39)

1. Haidari, M., N. Leung, F. Mahbub, K. D. Uffelman, R. Kohen-Avramoglu, G. F. Lewis, and K. Adeli. 2002. Fasting and post-prandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J. Biol. Chem. 277: 31646-31655.
2. Guo, Q., R. K. Avramoglu, and K. Adeli. 2005. Intestinal assembly and secretion of highly dense/lipid-poor apolipoprotein B48-containing lipoprotein particles in the fasting state: evidence for induction by insulin resistance and exogenous fatty acids. Metabolism. 54: 689-697. (Pubitemid 40585660)
3. Lewis, G. F., K. Uffelman, M. Naples, L. Szeto, M. Haidari, and K. Adeli. 2005. Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster. Endocrinology. 146: 247-255.
4. Risser, T. R., G. M. Reaven, and E. P. Reaven. 1978. Intestinal contribution to secretion of very low density lipoproteins into plasma. Am. J. Physiol. 234: E277-E281.
5. Ockner, R. K., F. B. Hughes, and K. J. Isselbacher. 1969. Very low density lipoproteins in intestinal lymph: origin, composition, and role in lipid transport in the fasting state. J. Clin. Invest. 48: 2079-2088.
6. Curtin, A., P. Deegan, D. Owens, P. Collins, A. Johnson, and G. H. Tomkin. 1996. Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotein B-48. Acta Diabetol. 33: 205-210.
7. Haffner, S. M., D. M. Foster, R. S. Kushwaha, and W. R. Hazzard. 1984. Retarded chylomicron apolipoprotein-B catabolism in type 2 (non-insulin- dependent) diabetic subjects with lipaemia. Diabetologia. 26: 349-354.
8. Duez, H., B. Lamarche, R. Valéro, M. Pavlic, S. Proctor, C. Xiao, L. Szeto, B. W. Patterson, and G. F. Lewis. 2008. Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans. Circulation. 117: 2369-2376.
9. Black, D. D. 2007. Development and physiological regulation of intestinal lipid absorption. I. Development of intestinal lipid absorption: cellular events in chylomicron assembly and secretion. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G519-G524.
10. Lu, S., Y. Yao, X. Cheng, S. Mitchell, S. Leng, S. Meng, J. W. Gallagher, G. S. Shelness, G. S. Morris, J. Mahan, et al. 2006. Overexpression of apolipoprotein A-IV enhances lipid secretion in IPEC-1 cells by increasing chylomicron size. J. Biol. Chem. 281: 3473-3483.
11. Lu, S., Y. Yao, S. Meng, X. Cheng, and D. D. Black. 2002. Overexpression of apolipoprotein A-IV enhances lipid transport in newborn swine intestinal epithelial cells. J. Biol. Chem. 277: 31929-31937.
12. Ge, H., G. Yang, X. Yu, T. Pourbahrami, and C. Li. 2004. Oligomerization state-dependent hyperlipidemic effect of angiopoietinlike protein 4. J. Lipid Res. 45: 2071-2079. (Pubitemid 40990901)
13. Gil-Villarino, A., E. Garcia-Fuentes, F. Zafra, and E. Garcia-Peregrin. 1998. Production of a rapid hypercholesterolemia in young chick by feeding coconut oil from two different sources and fatty acid composition. Nutr. Res. 18: 1273-1285.
14. Macias-Gonzalez, M., I. Moreno-Santos, J. M. García-Almeida, F. J. Tinahones, and E. Garcia-Fuentes. 2009. PPARgamma2 protects against obesity by means of a mechanism that mediates insulin resistance. Eur. J. Clin. Invest. 39: 972-979.
15. Cardona, F., F. J. Tinahones, E. Collantes, A. Escudero, E. García-Fuentes, and F. J. Soriguer. 2003. The elevated prevalence of apolipoprotein E2 in patients with gout is associated with reduced renal excretion of urates. Rheumatology (Oxford). 42: 468-472.
16. García-Fuentes, E., A. Gil-Villarino, M. F. Zafra, and E. García-Peregrín. 2000. Hypocholesterolemic activity of dipyridamole: effects on chick plasma and lipoprotein composition and arachidonic acid levels. Environ. Toxicol. Pharmacol. 8: 261-266.
17. Verseyden, C., S. Meijssen, and M. Castro Cabezas. 2002. Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemia. J. Lipid Res. 43: 274-280. (Pubitemid 34184014)
18. Vine, D. F., R. Takechi, J. C. Russell, and S. D. Proctor. 2007. Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome. Atherosclerosis. 190: 282-290.
19. Hogue, J. C., B. Lamarche, A. J. Tremblay, J. Bergeron, C. Gagne, and P. Couture. 2007. Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes. J. Lipid Res. 48: 1336-1342.
20. Vine, D. F., D. R. Glimm, and S. D. Proctor. 2008. Intestinal lipid transport and chylomicron production: possible links to exacerbated atherogenesis in a rodent model of the metabolic syndrome. Atheroscler. Suppl. 9: 69-76.
21. Nevin, P., D. Koelsch, and C. M. Mansbach 2nd. 1995. Intestinal triacylglycerol storage pool size changes under differing physiological conditions. J. Lipid Res. 36: 2405-2412.
22. Mansbach II, C. M., R. F. Dowell, and D. Pritchett. 1991. Portal transport of absorbed lipids in rats. Am. J. Physiol. 261: G530-G538.
23. Duez, H., B. Lamarche, K. D. Uffelman, R. Valero, J. S. Cohn, and G. F. Lewis. 2006. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans. Arterioscler. Thromb. Vasc. Biol. 26: 1357-1363.
24. Federico, L. M., M. Naples, D. Taylor, and K. Adeli. 2006. Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related kinase, and sterol regulatory element-binding protein-1c in the fructose-fed hamster intestine. Diabetes. 55: 1316-1326.
25. Hanniman, E. A., G. Lambert, Y. Inoue, F. J. Gonzalez, and C. J. Sinal. 2006. Apolipoprotein A-IV is regulated by nutritional and metabolic stress: involvement of glucocorticoids, HNF-4a, and PGC-1a. J. Lipid Res. 47: 2503-2514.
26. Attia, N., A. Touzani, M. Lahrichi, A. Balafrej, O. Kabbaj, and A. Girard-Globa. 1997. Response of apolipoprotein AIV and lipoproteins to glycaemic control in young people with insulin-dependent diabetes mellitus. Diabet. Med. 14: 242-247.
27. Black, D. D., and H. Ellinas. 1992. Apolipoprotein synthesis in newborn piglet intestinal explants. Pediatr. Res. 32: 553-558.
28. Ockner, R. K., and J. A. Manning. 1974. Fatty acid-binding protein in small intestine. Identification, isolation, and evidence for its role in cellular fatty acid transport. J. Clin. Invest. 54: 326-338.
29. Kindel, T., D. M. Lee, and P. Tso. 2010. The mechanism of the formation and secretion of chylomicrons. Atheroscler. Suppl. 11: 11-16.
30. Wetterau, J. R., L. P. Aggerbeck, M. E. Bouma, C. Eisenberg, A. Munck, M. Hermier, J. Schmitz, G. Gay, D. J. Rader, and R. E. Gregg. 1992. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science. 258: 999-1001.
31. Lewis, G. F., M. Naples, K. Uffelman, N. Leung, L. Szeto, and K. Adeli. 2004. Intestinal lipoprotein production is stimulated by an acute elevation of plasma free fatty acids in the fasting state: studies in insulin-resistant and insulin-sensitized Syrian golden hamsters. Endocrinology. 145: 5006-5012.
32. Phillips, C., K. Mullan, D. Owens, and G. H. Tomkin. 2006. Intestinal microsomal triglyceride transfer protein in type 2 diabetic and nondiabetic subjects: the relationship to triglyceride-rich postprandial lipoprotein composition. Atherosclerosis. 187: 57-64.
33. Liu, Y., M. Manchekar, Z. Sun, P. E. Richardson, and N. Dashti. 2010. Apolipoprotein B-containing lipoprotein assembly in microsomal triglyceride transfer protein-deficient McA-RH7777 cells. J. Lipid Res. 51: 2253-2264.
34. Dashti, N., M. Manchekar, Y. Liu, Z. Sun, and J. P. Segrest. 2007. Microsomal triglyceride transfer protein activity is not required for the initiation of apolipoprotein B-containing lipoprotein assembly in McA-RH7777 cells. J. Biol. Chem. 282: 28597-28608.
35. Kulinski, A., S. Rustaeus, and J. E. Vance. 2002. Microsomal triacylglycerol transfer protein is required for lumenal accretion of triacylglycerol not associated with ApoB, as well as for ApoB lipidation. J. Biol. Chem. 277: 31516-31525.
36. Wang, Y., K. Tran, and Z. Yao. 1999. The activity of microsomal triglyceride transfer protein is essential for accumulation of triglyceride within microsomes in McA-RH7777 cells. A unified model for the assembly of very low density lipoproteins. J. Biol. Chem. 274: 27793-27800.
37. Mandard, S., F. Zandbergen, E. van Straten, W. Wahli, F. Kuipers, M. Muller, and S. Kersten. 2006. The fasting-induced adipose factor/angiopoietin- like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J. Biol. Chem. 281: 934-944. [Erratum. 2006. J. Biol. Chem. 281: 21575.]
38. Yoshida, K., T. Shimizugawa, M. Ono, and H. Furukawa. 2002. Angiopoietin-like protein 4 is a potent hyperlipidemia inducing factor in mice and inhibitor of lipoprotein lipase. J. Lipid Res. 43: 1770-1772. (Pubitemid 35315796)
39. Xu, A., M. C. Lam, K. W. Chan, Y. Wang, J. Zhang, R. L. Hoo, J. Y. Xu, B. Chen, W. S. Chow, A. W. Tso, et al. 2005. Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc. Natl. Acad. Sci. USA. 102: 6086-6091.